Can the Healthcare System Afford a $795 Colorectal Cancer Screen?
Exact Sciences (Marlborough, MA) and its distribution partner, LabCorp (Burlington, NC), have announced the commercial roll out of PreGen-Plus, a proprietary DNA-based stool assay for the early detection of colorectal cancer. The homebrew test is being offered at a list price of $795 (or an estimated $400 to $600 after discounts).